Nuclear Medicine
CAPSUBAC
Name:
Capsubac-Sodium Iodide (131I)
Active Principle:
Sodium Iodide (131I)
Therapeutic Action:
It is indicated for the treatment of hyperthyroidism and in special cases of thyroid carcinoma. This medicine is for therapeutic use in:
– Graves’ disease, single or multiple diffuse toxic multinodular goiter or autonomous thyroid nodules.
– For the treatment of papillary and follicular carcinoma of the thyroid, including recurrent metastatic disease after surgery. Sodium iodide (131I) treatment is often associated with surgery and antithyroid drugs.
Nuclear Medicine
CAPSUBAC
Name:
Capsubac-Sodium Iodide (131I)
Active Principle:
Sodium Iodide (131I)
Therapeutic Action:
It is indicated for the treatment of hyperthyroidism and in special cases of thyroid carcinoma. This medicine is for therapeutic use in:
– Graves’ disease, single or multiple diffuse toxic multinodular goiter or autonomous thyroid nodules.
– For the treatment of papillary and follicular carcinoma of the thyroid, including recurrent metastatic disease after surgery. Sodium iodide (131I) treatment is often associated with surgery and antithyroid drugs.
RELATED PRODUCTS
-
131I MIBG BACON (R&D)
131I MIBG BACON (R&D)It is indicated for the diagnosis and location of neuroendocrine tumors, pheochromocytoma, medullary thyroid cancer, primary neuroblastomas and their metastases, paragangliomas and thymomas... -
PSMA (R+D)
PSMA (R+D)It is indicated for the detection and evaluation of prostate cancer from the initial diagnosis to the monitoring of castration-resistant metastases.

